Structural designing of suppressors for autisms spectrum diseases using molecular dynamics sketch by Nair, Bipin BJ et al.
  
 
International Journal of Drug Delivery 8 (2016) 142-146 
http://www.arjournals.org/index.php/ijdd/index 
 
 Original Research Article 
             
Structural designing of suppressors for autisms spectrum diseases using 
molecular dynamics sketch 
Bipin Nair BJ1, Vijesh Bhaskaran2*, Arunjit K3 
 
*Corresponding author: 
 
Vijesh  Bhaskaran 
 
1,2,3 Department of Computer Science 
1,2,3 Amrita School of Arts and 
Sciences, Mysuru Campus 
1,2,3 AmritaVishwaVidyapeetham, 
Amrita University, India 
 
 
A b s t r a c t  
In this paper we are sketching the chemical structure of suppressor drug for autism 
spectrum disorder using a computational tool .Here we are designing three  molecular 
compounds like Fluoxetine, Risperidone, Melatonin .Structuring the suppressors, 
sketching the aromatization and bonding of the functional groups withthe elements like 
Oxygen ,Nitrogen ,halogens. In our work we are using computational algorithm for  
drawing the structure of suppressor drug. In this paper we are mentioning the autism 
spectrum suppressor’s molecular formula as well as structural formula. 
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Introduction 
Cheminformatics is a technique which incorporate the Computer 
Science, Machine learning and chemistry mainly used for the drug 
prediction and drug discovery. It is branch of science which deal to 
solve the chemical drug related pattern using the modern 
approach. It also focuses on storing, extracting and indexing the 
chemical components. A Cheminformatics methodology has been 
adopted mainly in pharmaceutical for drug designing and discovery. 
[1] It has now emerged as an inevitable part in modern drug 
discovery. It uses computational method for designing and 
predicting the drug structure. 
Cheminformatics is a science that deals discovering and 
developing the drugs using [2] modern drug developing 
technologies that helps us to clear the faults or bugs that are 
present in the traditional drug development technologies. Designing 
a drug to is very complex task. [3] There are very few drugs which 
have efficient but have very less accuracy. But the accuracy of 
such drugs can be improved using the [4] Cheminformatics 
technology and thereby increasing the efficiency of the drug. 
 
Review of literature 
Cheminformatics deals with discovering drugs based in modern 
drug discovery methods which in turn rectifies complex issues in 
traditional drug discovery system.[5] Cheminformatics tools 
supports medical chemist for better understanding of complex 
structures of chemical compounds. : Jie Dong [6] projected that 
numerous tools have been developed to represent these 
components.  
However, they have some restrictionsie they only concentrate on 
the analysis of either small molecules or proteins or DNAs/RNAs. 
Thus there is still absence of freely available, easy to use and 
unified platforms for generating molecular descriptors of 
DNAs/RNAs, proteins, small molecules and their interactions. A 
method to understand protein–chemical interactions using 
heterogeneous input consisting of both protein sequence and 
chemical information was proposed by: Misagh Naderi [7] in a 
graph-based approach to construct Target focused libraries for 
virtual screening. In the paper of Deep Belief Networks for Ligand-
Based Virtual Screening of Drug Design by Aries Fitriawan [8] 
suggest about the virtual screening method in drug discovery the 
author talks about finding a new method for ligand-based virtual 
screening using machine learning technique here the classification 
has been done by using Deep Belief Networks (DBN) method 
which permit any inter-layer model of Restricted Boltzmann 
Machine (RBM) to receive a different depiction of the data from its 
output. Whereas the RBM is a simplification of the Boltzmann 
Machine models that have the energy formula of joint configuration. 
In Cheminformatics one of the important step in drug discovery is 
target prediction. : Zhonghua Wang [9] proposed that Silico target 
prediction of compounds plays insignificant role in drug discovery. 
After target Identification, validation phase starts by determining 
whether the modulation of the target will produce a desired clinical 
result.[10] Binary classifiers using the  machine learning were 
developed for calculating the reactivity of potential substrates and 
products in the 12 classes of oxidoreductase-catalyzed reactions. 
[11] A technique to infer protein–chemical interactionsusing 
heterogeneous input consisting of both protein sequenceand 
chemical information.[12] user-friendly web-based software, named 
Drug-SN Ping, which provides a platform for the integration of drug 
information.[13] Several variant genotypes along with the 
development of Quasi-species restricted the effectiveness of drugs 
used for the treatment of HCV infections. This heterogeneity of the 
virus hindered the drug development against them. [14] The Latest 
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study uses Ferric binding protein, which is used as a reference 
molecule to understand high reactive responses of various drugs 
administered for the oral periodontitis. The drugs are being 
compared with the Fbp. The Fbp interacted with doxycycline, 
flurbiprofen and chlorhexidine using docking methods. [10] Various 
computational methodologies have been suggested for the 
calculation of compound toxicity ranging from quantitative structure 
activity relationship modelling to molecular similarity-based 
approaches and machine learning. 
Problem formulation 
For autism spectrum disorder doesn’t have specific proper drug to 
cure the diseases. [15] Tradition drug suppressor discovery 
methodadopted for the autism uses experimental methods and 
manual procedures which were time consuming and highly 
expensive. [16] The autism drug discovered using tradition 
methods was not efficient and accurate. Thus experiments has to 
be carried out several time in order to achieve the proper result. 
[17]Using the Cheminformatics techniques it is possible to change 
the chemical structure of aautism drug with the perfect accuracy 
and efficiency by using the molecular dynamics concepts. 
 
Problem definition 
Autism is a spectrum of disorder which varies from one person to 
another person. Autism is a genetically disorder that are usually 
visible in children. There are very few drugs which could reduce the 
symptom. However these drug lack the accuracy and efficiency.  
Our works aims to give awareness to public about the structure of 
autism spectrum disorder suppressors using molecular dynamics, 
sketching the suppressor and in future work we can redesign the 
suppressor to change the element positions and increase the 
efficiency. 
 
COMPOUND NAME MOLECULAR FORMULA 
FLUOXETINE C17H18F3NO 
MELATONIN C13H16N2O2 
RISPERIDONE C23H27FN4O2 
 
Table 1: Table For Drug Compound name and Molecular formula 
 
The table 1 which given above is to describe the suppressors which 
we have taken for this paper work to sketch the structure 
 
Flow diagram for drug designing of Asd 
 
 
Figure 1: Working of Gene Predictor 
 
Methodology 
Input: mol file for the suppressor 
1. Identify the suppressor. 
2. Identify the focusing area of the drug on the autism. 
3. Identify the aromatization and bonding the functional groups with 
the elements like Oxygen, Nitrogen, halogens. 
4. dlg. Filter = 
*.mol|*.mol|*.cdx|*.cdx|*.cdxml|*.cdxml|*.rxn|*.rxn|*.mrv|*.mrv|*.cml|*
.cml|*.mol2|*.mol2|*.tgf|*.tgf|*.smi"; 
5. if (dlg. Show Dialog()) 
6. using (Open File Dialogdlg = new Open File Dialog()) 
7. dlg. Filter = "*.sdf|*.sdf"; 
8. if (dlg. Show Dialog() == System. Windows. Forms. Dialog 
Result. OK) 
9. sdf File. Text = dlg. File Name; 
10..if (pe. Result!= System. Windows. Forms. Dialog Result. OK) 
11.return; 
12.structure = pe.Html; 
13. Molecule m = Molecule. Read (structure); 
14.string smiles = m. To String("smiles"); 
15.stringmolfile = m. To String ("molfile"); 
16.pictureBox1.Image = m. ToImage 
(pictureBox1.ClientSize.Width, pictureBox1.ClientSize.Height, 10); 
The above psuedocode explains how to draw a chemical structure 
of the autism drug. The data relating to the existing drug has to be 
collected from ChEMBL in order to draw the structure. The 
extension has to be saved in mol or cdx, cd, cdxml etc. The drug 
has being designed in the picture box bydrag and drop method. 
The basic chemical structure has been mapped to the picture box. 
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Experimental result 
DATASET: 
These are the following suppressor which we are using for the 
experiment result 
 
Compound ID CHEMBL85 
Compound Name 
  
RISPERIDONE 
ChEMBL Synonyms Risperdal Consta Long Acting | 
R 64 766 | Risperdal consta | 
R-64766 | Risperdal M-TAB | 
R-64-766 | Risperdal | 
Risperdal M | RISPERIDONE 
Trade Names 
  
RISPERIDONE | Risperdal 
consta | Risperdal | Risperdal 
Consta Long Acting | Risperdal 
M-TAB | Risperdal M 
Molecular Formula 
  
C23H27FN4O2 
 
 
 
Figure 2:-The chemical structure of the Fluoxetine Drug 
. 
The figure shows the chemical structure of the autism drug called 
fluoxetine. Fluoxetine is a drug which is under the clinical trial 
testing the efficiency of the drug. This aim of the drug to reverse 
avoidance behaviors and ameliorate social deficits. This drug is 
used to reduce the symptoms of the panic disorders.in this drug we 
are sketched aromatizationusing functional group halogens. 
Figure 3:-The chemical structure of the Melatonin Drug. 
 
The above structure represent the chemical structure of the 2nd 
suppressor drug called Melatonin. The drug targets the brain 
neurons causing the depression and sleeping disorder. This drug 
has been used for the treatment of the autism patient having the 
sleeping disorder and regulates the creation of hormones such as 
cortisol and serotonin. In this drug we are used aromatization using 
a functional group amine. 
 
Compound ID CHEMBL41 
Compound Name FLUOXETINE 
ChEMBL Synonyms  
PROZAC WEEKLY | 
FLUOXETINE 
HYDROCHLORIDE | LY-
110140 | SARAFEM | PROZAC 
| Sarafem | Symbyax | 
FLUOXETINE | Prozac 
Trade Names 
SARAFEM | FLUOXETINE 
HYDROCHLORIDE | PROZAC 
WEEKLY | FLUOXETINE | 
PROZAC 
Molecular Formula C17H18F3NO 
Compound ID CHEMBL45  
Compound Name MELATONIN 
ChEMBL Synonyms  
N-ACETYL-5-
METHOXYTRYPTAMINE | N-(2-
(5-METHOXY-1H-INDOL-3-
YL)ETHYL)ACETAMIDE | 
MELATONIN 
Trade Names unknown 
Molecular Formula C13H16N2O2 
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Figure 4: -The chemical structure of the Risperidone Drug. 
 
The above figure depicts the chemical structure of the Risperidone 
drug which is an antidepressant drug which focuses on treating the 
autism children with aggression and self-injury tendencies. Thus 
there are several side effects for the particular drugs such as 
weight gaining. In this structure we have sketched aromatization 
with the various elements like N,O,F.  
 
Conclusion 
In this paper we are designing the suppressor drug for autism 
spectrum diseases using computational tool. Using molecular 
dynamics concept sketching the structural formula for suppressor 
using Cheminformatics and molecular dynamics methods. 
We can extend the work, for redesigning these suppressors to 
change the functional group positions and consider the isomers of 
the same compound in that way we can increase the efficiency a 
proper drug for autism diseases using all the possible structural 
change with all permutations and combinations and reducing the 
side effects . 
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